ArticleAnalytical chemistry2026
Rapid Chiral Analysis of Drugs with Multiple Stereocenters via High-Resolution Ion Mobility.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The increasing structural complexity of small-molecule therapeutics requires sensitive analytical techniques that facilitate rapid chiral analysis of drugs with multiple chiral centers. Here, we demonstrate ultrafast chiral separations for compounds possessing 3 chiral centers (8 stereoisomers, 4 enantiomer pairs) using gas-phase ion mobility spectrometry-mass spectrometry (IM-MS). Separations are achieved using spontaneous noncovalent copper-tyrosine complexation.This complexation strategy converts all stereoisomers into diastereomers that are structurally distinguishable by IM-MS. Notably, this strategy is over 3 orders of magnitude faster than traditional liquid-phase chiral chromatography (ms vs min, respectively). Using IM-MS, we achieved direct baseline separation of enantiomer pairs and progress toward differentiation of all 8 stereoisomers. Results suggest that higher-order complexes (i.e., copper-tyrosine-bound drug dimers) enhance chiral differentiation at the expense of increased spectral complexity. Exchanging the chirality of the amino acid for complexation resulted in an inversion of separation elution ordering. Peak fitting analysis suggests that an IM resolving power of several thousand is necessary to resolve all stereoisomers for quantitative purposes, which is approximately an order of magnitude higher than the current state-of-the-art. Collectively, these findings demonstrate the speed and versatility of gas-phase ion mobility spectrometry for complex chiral analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.